Psychedelic-Assisted Therapy for Addiction and Co-Occurring Disorders
Innovative Treatments for Effective Recovery
- Speaker:
- Chantelle Thomas, PhD
- Duration:
- 1 Hour 32 Minutes
- Format:
- Audio and Video
- Copyright:
-
Oct 27, 2023
- Product Code:
- POS059604
- Media Type:
- Digital Seminar
Description
The world of psychedelics is captivating minds and sparking curiosity like never before. As dedicated therapists, it's not just an option but an imperative to stay informed about the clinical realm of these substances and the transformative potential they hold. The key lies in understanding the crucial distinction between recreational consumption and their integration within an intentional therapeutic framework and a solid therapeutic alliance.
Amidst the burgeoning interest, it's essential to discern the reality from the hype. While psychedelics might seem like a shortcut, the truth is more intricate. These compounds aren't a magical cure-all or an escape from the work of authentic healing and enduring recovery. It's paramount to explore their potential within a therapeutic context and grasp the nuanced conversations they entail.
This presentation is your gateway to uncovering the potential of these therapies as adjunctive tools for treating addiction and other co-occurring disorders. It will highlight clients who may be appropriate for this treatment and explore the potential risks and opportunities of using psychedelics for therapeutic purposes. Become the beacon of clarity as you demystify misconceptions and lay the foundation for responsible, evidence-based practice.
Credit
Speaker
Chantelle Thomas, PhD Related seminars and products
Dr. Chantelle Thomas is a clinical psychologist and executive clinical director of Windrose Recovery – a multi-level residential addiction treatment program offering detoxification, intensive outpatient programming, and integrated ketamine-assisted psychotherapy. Dr. Thomas has been directly involved in clinical research trials at the University of Wisconsin School of Medicine and Public Health investigating the clinical use of psychedelics for over nine years. Current trials include the study of psilocybin for addiction and depression and MDMA for PTSD. She currently serves as a supervisor and trainer on the MAPS sponsored clinical trials of MDMA-assisted psychotherapy for PTSD for US and European clinical trials and Expanded Access Program. Dr. Thomas completed a postdoctoral fellowship in health psychology at the University of Wisconsin School of Medicine and Public Health and is a certified biofeedback practitioner. Her areas of specialization include chronic pain, trauma-related disorders, substance use disorders, and psychedelic integration.
Speaker Disclosures:
Financial: Dr. Chantelle Thomas has employment relationships with Integrata Healing, Windrose Recovery, The Manor, Dane County, and the University of Wisconsin. She receives a consulting fee from Usona Institute, Lykos, Polaris Institute, and MindMed. Dr. Thomas is a trainer with Fluence Training and a podcast host of Blind Spots. She is a therapist who is working on a clinical trial sponsored by Revive Therapeutics and Beckley Ltd. Dr. Thomas receives a speaking honorarium from Psychotherapy Networker and PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Dr. Chantelle Thomas has no relevant non-financial relationships.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Describe the Psychedelic Assisted Therapy (PAT) model, including its key components and potential risks.
- Outline a comprehensive overview of Psychedelic Assisted Therapy (PAT) research for addiction, including significant studies, findings, and trends.
- Articulate potential therapeutic mechanisms of PAT for addiction.
- Explain special considerations for eligibility, suitability, and co-occurring conditions in the context of Psychedelic Assisted Therapy (PAT) for addiction.
Outline
Psychedelic Assisted Therapy (PAT) model and potential risks
Latest research on PAT for addiction
Potential therapeutic mechanisms of PAT for addiction
Special considerations for eligibility, suitability, and co-occurring conditions
Target Audience
- Addiction Professionals
- Case Managers
- Licensed Clinical/Mental Health Counselors
- Marriage & Family Therapists
- Psychologists
- Social Workers
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...



